Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cost of disorders of the brain in Spain.
Selective JAK1 inhibitor and selective Tyk2 inhibitor patents.
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.
Aging, widowhood, multiple sclerosis, and a dog.
The nervous system's potential role in multiple sclerosis associated bone loss.
Effects of Imatinib Mesylate in Mouse Models of Multiple Sclerosis and In vitro Determinants.
[Damage of macular ganglion cell complex and peripapillary retinal nerve fiber layer in multiple sclerosis.]
The impact of walking speed on the effects of functional electrical stimulation for foot drop in people with multiple sclerosis.
[Case report: a case of chronic inflammatory demyelinating polyneuropathy (CIDP) exacerbated by influenza vaccination].
Early detection of MS treatment complication may improve survival
Anesthetic management of a parturient with neuromyelitis optica.
Post-Partum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother.
Neuroprotection With Riluzole Patients With Early Multiple Sclerosis
Four different synthetic peptides of proteolipid protein induce a distinct antibody response in MP4-induced experimental autoimmune encephalomyelitis.
Experimental autoimmune encephalomyelitis.
Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy.
Superficial spreading malignant melanoma in a patient on fingolimod therapy for multiple sclerosis.
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation.
Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohort.
The role of regulatory T cells in neurodegenerative diseases.
Cannabis and Cannabinoids (PDQ®)
Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia.
Autologous T Cell Vaccine (TCV) for Multiple Sclerosis (TERMS)
PLA2G6 mutations and other rare causes of Neurodegeneration with Brain Iron Accumulation.
Pages
« first
‹ previous
…
181
182
183
184
185
186
187
188
189
…
next ›
last »